Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma
- 1 May 1990
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 116 (3) , 301-302
- https://doi.org/10.1007/bf01612907
Abstract
Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment.Keywords
This publication has 10 references indexed in Scilit:
- Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanomaZeitschrift für Krebsforschung und Klinische Onkologie, 1989
- INVITRO PHARMACODYNAMICS OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE - SYNERGY OF ANTITUMOR-ACTIVITY WITH CIS-DIAMMINEDICHLOROPLATINUM(II)1988
- WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.Journal of Clinical Oncology, 1987
- PHASE-II TRIAL OF CARBOPLATIN IN ADVANCED MALIGNANT-MELANOMA1987
- CYTARABINE AND CISPLATIN IN ADVANCED MALIGNANT-MELANOMA1986
- LACK OF SYNERGY BETWEEN CISPLATIN AND CYTARABINE AGAINST OVARIAN-CARCINOMA INVITRO1986
- Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-beta-D-arabinofuranosylcytosine.1981
- Pharmacokinetics of cytosine arabinoside in acute myeloid leukemiaClinical Pharmacology & Therapeutics, 1977
- "Platinum-pyrimidine blues" and related complexes: a new class of potent antitumor agents.1975
- Chemotherapy of malignant melanomaCancer, 1972